Prevention of Cow's Milk Allergy in Children
Use of Fermented Milk in Prevention of Cow's Milk Allergy in New Born and Infant
1 other identifier
interventional
142
1 country
2
Brief Summary
Impact of fermented milk in prevention of cow's milk allergy in new born and infants
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2003
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2003
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2008
CompletedFirst Submitted
Initial submission to the registry
November 14, 2008
CompletedFirst Posted
Study publicly available on registry
November 17, 2008
CompletedNovember 17, 2008
November 1, 2008
4.5 years
November 14, 2008
November 14, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Sensibilisation and cow's milk allergy
4, 12 and 24 months
Secondary Outcomes (2)
Sensitization or allergy to other allergens
4, 12 and 24 months
Atopic diseases (atopic dermatitis, asthma)
4, 12 and 24 months
Study Arms (2)
1
EXPERIMENTALFermented milk
2
ACTIVE COMPARATORStandard milk
Interventions
Eligibility Criteria
You may qualify if:
- mother before the 5th month of pregnancy
- mother agreeing to stop consumption of yogurts and fermented milks during the 3rd quarter of pregnancy
- mother agreeing to receive a calcium supplementation during the 3rd quarter of pregnancy
- atopic mother or father and at least another atopic member (sister or brother)
- parents having given written informed consent
- adhesion to eviction regimen for mother and child
- parents agreeing with a regular follow-up (3 visits and monthly phone call with the dietician)
You may not qualify if:
- parents refusing to sign the informed consent
- infant in a situation which could interfere with an optimal participation to the study, or which could represent a risk for the infant, according to the investigator
- known or suspected immunodeficiency in the family
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Bledinalead
- Optimed Medizinische Instrumente GmbHcollaborator
Study Sites (2)
Hôpital central
Nancy, 57000, France
Hôpital Saint Vincent de Paul
Paris, 75014, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christophe Dupont, PhD
Hôpital Saint Vincent de Paul
- PRINCIPAL INVESTIGATOR
Denise-Anne Moneret-Vautrin, PhD
Hôpital central
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
November 14, 2008
First Posted
November 17, 2008
Study Start
November 1, 2003
Primary Completion
May 1, 2008
Study Completion
July 1, 2008
Last Updated
November 17, 2008
Record last verified: 2008-11